Skip to main content

Featured

How Canadian Savers Can Protect Their Money in 2026

As 2026 unfolds, Canadian savers are navigating a financial landscape shaped by falling interest rates, persistent living‑cost pressures, and evolving tax‑advantaged opportunities. Experts say this is the year to be intentional, strategic, and proactive with your money. Reevaluate Your Savings Accounts Interest rates have been trending downward, and many high‑interest savings accounts have quietly reduced their payouts. GIC rates remain more stable, but they too are expected to soften as rate cuts continue. What to do now: Check the current rate on every savings account you hold Compare alternatives and switch if your rate has dropped significantly Consider laddering GICs to lock in competitive yields while they’re still available Make the Most of Your TFSA The Tax‑Free Savings Account remains one of the most powerful tools for Canadians. With annual contribution room increasing over time, it’s an ideal place to shelter both short‑term savings and long‑term investments. Why...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment